IPO registrations (S-1, F-1) · Registrants
CUMBERLAND PHARMACEUTICALS INC
- SEC CIK
- 1087294 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2007-05-01, last 2009-07-29; 1 initial registration, 20 amendments
- Outcome
- Final prospectus filed 2009-08-12; declared effective 2009-08-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- TN
- Business address
- 1600 WEST END AVENUE, SUITE 1300, Nashville,, TN 37203
- EIN
- 62-1765329
- Ticker
- CPIX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- CUMBERLAND PHARMACEUTICALS INC on the corporate pages
On this site
- Business registration: Cumberland Pharmaceuticals Inc. Fuzzy (name and state)
- Business registration: Cumberland Pharmaceuticals Inc. Fuzzy (name and state)
- Business registration: CUMBERLAND PHARMACEUTICALS INC. Fuzzy (name and state)
- Business registration: CUMBERLAND PHARMACEUTICALS INC. Fuzzy (name and state)
- Business registration: CUMBERLAND PHARMACEUTICALS INC. Fuzzy (name and state)
- Business registration: CUMBERLAND PHARMACEUTICALS INC. Fuzzy (name and state)
- Form 5500 plan sponsor: CUMBERLAND PHARMACEUTICALS INC. EXACT (EIN (EXACT))
- Federal award recipient: CUMBERLAND PHARMACEUTICALS, INC. Fuzzy (name and state)
- Lobbying client: CUMBERLAND PHARMACEUTICALS Fuzzy (name and state)
- SEC filer: CUMBERLAND PHARMACEUTICALS INC EXACT (CIK (EXACT))
Filings 23
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2007-05-01 | S-1 | S-1 (registration) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-004069 ↗ |
| 2007-06-22 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-005944 ↗ |
| 2007-07-06 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-006409 ↗ |
| 2007-07-11 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-006504 ↗ |
| 2007-07-23 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-006748 ↗ |
| 2007-08-06 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-007248 ↗ |
| 2007-08-29 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-008253 ↗ |
| 2007-11-16 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-07-010587 ↗ |
| 2008-02-01 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-000576 ↗ |
| 2008-02-19 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-001141 ↗ |
| 2008-05-21 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-004306 ↗ |
| 2008-06-09 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-004684 ↗ |
| 2008-06-20 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-004970 ↗ |
| 2008-08-12 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-006395 ↗ |
| 2008-11-12 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-08-008496 ↗ |
| 2009-02-18 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-09-001408 ↗ |
| 2009-03-18 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-09-002353 ↗ |
| 2009-04-10 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-09-003082 ↗ |
| 2009-05-12 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950144-09-004230 ↗ |
| 2009-07-17 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950123-09-023228 ↗ |
| 2009-07-29 | S-1/A | S-1/A (amendment) | CUMBERLAND PHARMACEUTICALS INC | 0000950123-09-026938 ↗ |
| 2009-08-10 | EFFECT | EFFECT (declared effective) | CUMBERLAND PHARMACEUTICALS INC | 9999999995-09-002211 ↗ |
| 2009-08-12 | 424B4 | 424B4 (final prospectus) | CUMBERLAND PHARMACEUTICALS INC | 0000950123-09-033693 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bernard Gordon R | Director; Officer | Senior Vice President | 28 | 2009–2019 | |
| Cearnal Martin E | Director; Director,Officer | Sr VP/Chief Commercial Officer | 26 | 2009–2022 | |
| Edwards Robert | Director | 12 | 2009–2014 | ||
| Greer Lawrence W | Director | 8 | 2009–2012 | ||
| KAZIMI A J | Director,Officer,TenPercentOwner | Chairman and CEO | 70 | 2009–2026 | |
| Lawrence Thomas R | Director | 22 | 2009–2017 | ||
| Lowrance David L | Officer | Vice President and CFO | 4 | 2009–2011 | |
| Marstiller Jean W | Officer | Sr. VP & Corp. Secretary | 8 | 2009–2012 | |
| Pavliv Leo | Officer | Sr. Vice President, Operations; SVP and Chief Development Off.; Vice President, Operations | 27 | 2009–2022 | |
| Griggs Jonathan | Director | 16 | 2010–2021 | ||
| Jones James | Director | 56 | 2010–2026 | ||
| JACOBS JOEY A | Director | 20 | 2011–2023 | ||
| Greene Rick Scott | Officer | Chief Financial Officer | 6 | 2011–2015 | |
| Herman James L | Officer | See Remarks; VP and Chief Compliance Office; VP and Corporate Compliance | 19 | 2013–2026 | |
| Bonner Michael | Officer | Chief Financial Officer | 14 | 2016–2021 | |
| Rock Amy | Officer | See Remarks | 1 | 2016 | |
| Young Caroline | Director | 59 | 2016–2026 | ||
| Krogulski Kenneth | Director | 59 | 2017–2026 | ||
| Galante Joseph C | Director | 33 | 2018–2026 | ||
| Hamm John M. | Officer | Chief Financial Officer; VP Chief Financial Officer | 8 | 2021–2026 | |
| Brown Martin S JR | Director | 6 | 2022–2026 | ||
| Anthony Todd M. | Officer | Vice Pres Organizational Dev | 5 | 2023–2026 | |
| Bitterman Chris T. | Officer | Vice Pres Sales & Marketing | 5 | 2023–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.